PharmAthene (PIP:ASE) and InspireMD (NSPR:ASE) Trading at Less than Cash Value

I have used the analysis tools on the website to generate some of the content of this blog post. These tools and reports are available for free at

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on AMEX

Today’s data is for companies listed on the American Stock Exchange.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
PIP PharmAthene Inc 0.940400 68815195 0.5313 0.4745 1.00 0.25
LEU Centrus Energy Corp 5.960000 9000000 None None 18.98 -7.03
MSN Emerson Radio Corp 1.290000 27065852 None 0.6411 1.54 0.97
ALN American Lorain Corp 0.589900 38274490 58.9900 0.1147 0.98 -0.62
IMUC ImmunoCellular Therapeutics Ltd 2.700000 3444895 None 0.7997 4.44 None
NSPR InspireMD Inc 2.080000 1472606 None 0.7572 5.10 3.28

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

PIP:ASE PharmAthene
PharmAthene has 11 employees and is headquartered in United States.
PharmAthene Inc is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

InspireMD has 34 employees and is headquartered in Israel.
InspireMD Inc is a medical device company. The Company is engaged in the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease.

Free Valuation

Run a valuation on any of the companies listed above at or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.